Growth Metrics

Scholar Rock Holding (SRRK) Cash from Investing Activities (2017 - 2026)

Scholar Rock Holding's quarterly Cash from Investing Activities came in at -$5.3 million in Q1 2026, down 115.44% year-on-year from $34.6 million in Q1 2025, and down 113.69% quarter-over-quarter from $39.0 million in Q4 2025.

Scholar Rock Holding has reported Cash from Investing Activities for 10 years, with the latest figure at -$5.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 115.44% year-over-year to -$5.3 million; the trailing twelve-month figure through Mar 2026 stood at $178.8 million (up 338.76% YoY), and the FY2025 full-year result was $218.7 million, up 387.53% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$5.3 million, down from $39.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $90.0 million in Q1 2023, with the low at -$195.4 million in Q4 2024.
  • Average Cash from Investing Activities over 5 years is $396411.8, with a median of $33.4 million recorded in 2024.
  • Year-over-year, Cash from Investing Activities tumbled 32733.77% in 2023 and jumped 516.71% in 2024.
  • Tracing SRRK's Cash from Investing Activities over 5 years: stood at $77000.0 in 2022, then plunged by 32733.77% to -$25.1 million in 2023, then sank by 677.5% to -$195.4 million in 2024, then jumped by 119.95% to $39.0 million in 2025, then sank by 113.69% to -$5.3 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$5.3 million (Q1 2026), $39.0 million (Q4 2025), and $59.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.89 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -25.54 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - -5.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.34 Mn
Mar 31, 2026 -5.34 Mn
Dec 31, 2025 38.97 Mn
Dec 31, 2025 38.97 Mn
Sep 30, 2025 59.70 Mn
Sep 30, 2025 59.70 Mn
Jun 30, 2025 85.47 Mn
Jun 30, 2025 85.47 Mn
Mar 31, 2025 34.55 Mn
Mar 31, 2025 34.55 Mn
Dec 31, 2024 -195.37 Mn
Dec 31, 2024 -195.37 Mn
Sep 30, 2024 35.31 Mn
Sep 30, 2024 35.31 Mn
Jun 30, 2024 50.62 Mn
Jun 30, 2024 50.62 Mn
Mar 31, 2024 33.38 Mn
Mar 31, 2024 33.38 Mn
Dec 31, 2023 -25.13 Mn
Dec 31, 2023 -25.13 Mn
Sep 30, 2023 -8.47 Mn
Sep 30, 2023 -8.47 Mn
Jun 30, 2023 -15.24 Mn
Jun 30, 2023 -15.24 Mn
Mar 31, 2023 89.98 Mn
Mar 31, 2023 89.98 Mn
Dec 31, 2022 77,000.00
Dec 31, 2022 77,000.00
Sep 30, 2022 -145.72 Mn
Sep 30, 2022 -145.72 Mn
Jun 30, 2022 44.52 Mn
Jun 30, 2022 44.52 Mn
Mar 31, 2022 -70.58 Mn
Mar 31, 2022 -70.58 Mn
Dec 31, 2021 29.46 Mn
Dec 31, 2021 29.46 Mn
Sep 30, 2021 3.28 Mn
Sep 30, 2021 3.28 Mn
Jun 30, 2021 79.02 Mn
Jun 30, 2021 79.02 Mn
Mar 31, 2021 22.56 Mn
Mar 31, 2021 22.56 Mn
Dec 31, 2020 -122.64 Mn
Dec 31, 2020 -122.64 Mn
Sep 30, 2020 -35.87 Mn
Sep 30, 2020 -35.87 Mn
Jun 30, 2020 38.93 Mn
Jun 30, 2020 38.93 Mn
Mar 31, 2020 56.09 Mn
Mar 31, 2020 56.09 Mn
Dec 31, 2019 21.21 Mn
Dec 31, 2019 21.21 Mn
Sep 30, 2019 -72.17 Mn
Sep 30, 2019 -72.17 Mn
Jun 30, 2019 21.10 Mn
Jun 30, 2019 21.10 Mn
Mar 31, 2019 -32.38 Mn
Mar 31, 2019 -32.38 Mn
Dec 31, 2018 -60.94 Mn
Dec 31, 2018 -60.94 Mn
Sep 30, 2018 -598,000.00
Sep 30, 2018 -598,000.00
Jun 30, 2018 24.89 Mn
Jun 30, 2018 24.89 Mn
Mar 31, 2018 -23.59 Mn
Mar 31, 2018 -23.59 Mn
Dec 31, 2017 5.90 Mn
Dec 31, 2017 5.90 Mn
Sep 30, 2017 8.98 Mn
Sep 30, 2017 8.98 Mn